Latest Breaking News On - Julie dicarlo - Page 1 : vimarsana.com

Rapport Therapeutics Announces Pricing of Initial Public

BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on.

New yorkUnited statesSan franciscoJulie dicarloExchange commissionGoldman sachs coRapport therapeutics incProspectus departmentNicolaus company incorporatedHead of communicationsEquity syndicate prospectus departmentTd securities united statesNasdaq global marketSecurities actGoldman sachsOne montgomery street

Rapport Therapeutics Announces Pricing of Initial Public Offering

Rapport Therapeutics Announces Pricing of Initial Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoNew yorkJulie dicarloHead of communicationsTd securities united statesRapport therapeutics incProspectus departmentGoldman sachs coExchange commissionEquity syndicate prospectus departmentNicolaus company incorporatedTherapeutics announces pricingInitial publicNasdaq global marketSecurities act

Rapport Therapeutics Announces Pricing of Initial Public Offering

07.06.2024 - BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) - Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from .

United statesSan franciscoNew yorkJulie dicarloGoldman sachs coHead of communicationsEquity syndicate prospectus departmentProspectus departmentNicolaus company incorporatedTd securities united statesExchange commissionSecurities actGoldman sachsOne montgomery street

Form 424B3 Akili, Inc

Form 424B3 Akili, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSantosh shanbhagJulie dicarloEddie martucciApple app store onDrug administrationPublic health emergencyExchange commissionSecurities exchangeAkili incExchange commission onRegistration statementCurrent reportNasdaq capital marketSecurities exchange actEarliest event reported

Akili, Inc (NASDAQ:AKLI) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to the Akili Fourth Quarter 2022 Earnings Call. As a reminder, this conference is being recorded.

United statesSantosh shanbhagRahul rakhitJulie dicarloNicholas japhetScott kollinsJudah frommerEddie martucciVikram purohitMichael chernyMatt franklinMatthew franklinMorgan stanleyAkili incCredit suisseDuke university